Annual Meeting on Supportive Care in Cancer

home / conference / annual-meeting-on-supportive-care-in-cancer
Dexamethasone Sparing with Cisplatin-Based Chemotherapy Does Not Significantly Impact QoL

Dexamethasone Sparing with Cisplatin-Based Chemotherapy Does Not Significantly Impact QoL

Kyle Doherty
July 7th 2022

Dexamethasone sparing in cisplatin-based chemotherapy did not impair global health status, although it did worsen nausea and appetite loss.

Virtual Planning For Surgical Reconstruction May Improve Outcomes for Patients With Head and Neck Cancer

Virtual Planning For Surgical Reconstruction May Improve Outcomes for Patients With Head and Neck Cancer

Lindsay Fischer
June 29th 2022

Mandible reconstruction and maxilla reconstruction surgeries might be optimized with virtual surgical planning, according to an expert speaker at the 2022 Supportive Care in Cancer Annual Meeting.

Experts Make the Case for Buprenorphine Use in Cancer-Related Pain Management

Experts Make the Case for Buprenorphine Use in Cancer-Related Pain Management

Lindsay Fischer
June 28th 2022

Mary Lynn McPherson, PharmD, BCPS, FAAHPM, and Amy A. Case, MD, FAAHPM, argue that buprenorphine should play a larger role in cancer-related pain management because of its unique pharmacology and consequent safety profile.

Biosimilars May Reduce Disparities in Febrile Neutropenia Treatment

Biosimilars May Reduce Disparities in Febrile Neutropenia Treatment

Lindsay Fischer
June 27th 2022

At the 2022 Supportive Care in Cancer Annual Meeting, Jeffrey Crawford, MD, highlighted the potential value of biosimilars in reducing gaps in care for the treatment of febrile neutropenia.